Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M200307200 on April 8, 2002

J. Biol. Chem., Vol. 277, Issue 27, 24073-24080, July 5, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/27/24073    most recent
M200307200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fairley, K.
Right arrow Articles by Mackay, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fairley, K.
Right arrow Articles by Mackay, J. P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Type I Shorthorn Sculpin Antifreeze Protein

RECOMBINANT SYNTHESIS, SOLUTION CONFORMATION, AND ICE GROWTH INHIBITION STUDIES*

Kayesh FairleyDagger §, Belinda J. Westman§, Linda H. Pham||, A. D. J. Haymet||**, Margaret M. HardingDagger DaggerDagger, and Joel P. Mackay§§§

From the Dagger  School of Chemistry and the § Department of Biochemistry, University of Sydney, New South Wales 2006, Australia and the || Department of Chemistry, University of Houston, Houston, Texas 77204-5003

Received for publication, January 11, 2002, and in revised form, March 25, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

A number of structurally diverse classes of "antifreeze" proteins that allow fish to survive in sub-zero ice-laden waters have been isolated from the blood plasma of cold water teleosts. However, despite receiving a great deal of attention, the one or more mechanisms through which these proteins act are not fully understood. In this report we have synthesized a type I antifreeze polypeptide (AFP) from the shorthorn sculpin Myoxocephalus scorpius using recombinant methods. Construction of a synthetic gene with optimized codon usage and expression as a glutathione S-transferase fusion protein followed by purification yielded milligram amounts of polypeptide with two extra residues appended to the N terminus. Circular dichroism and NMR experiments, including residual dipolar coupling measurements on a 15N-labeled recombinant polypeptide, show that the polypeptides are alpha -helical with the first four residues being more flexible than the remainder of the sequence. Both the recombinant and synthetic polypeptides modify ice growth, forming facetted crystals just below the freezing point, but display negligible thermal hysteresis. Acetylation of Lys-10, Lys-20, and Lys-21 as well as the N terminus of the recombinant polypeptide gave a derivative that displays both thermal hysteresis (0.4 °C at 15 mg/ml) and ice crystal faceting. These results confirm that the N terminus of wild-type polypeptide is functionally important and support our previously proposed mechanism for all type I proteins, in which the hydrophobic face is oriented toward the ice at the ice/water interface.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The type I AFPs1 found in the blood of cold water teleosts (1-3) have attracted significant interest, due to the potential applications of such compounds in biotechnology and medicine (4-9). These compounds are alanine-rich alpha -helical proteins of 33-47 residues in length (for reviews see Refs. 10-13). Although 14 type I proteins have been identified in nature (summarized in Ref. 12), almost all studies to date have centered on HPLC6, the 37-residue protein from the winter flounder (see Table I below) (14). This protein is characterized as an AFP, because it modifies both the rate and shape of ice crystal growth and displays thermal hysteresis, i.e. a positive difference between the ice growth temperature and the equilibrium melting temperature of ice.

During the last decade, significant progress has been made in elucidating the structural features of HPLC6 that are required to give antifreeze activity. Structure-activity studies have identified the importance of the Thr residues at positions 2, 13, 24, and 35 plus surrounding residues, for ice growth inhibition activity. Although the Thr residues were assumed to be involved in hydrogen-bonding interactions with ice for many years (15-19), more recent mutations have identified the hydrophobicity provided by the gamma -methyl group of Thr as a key factor related to the ability to inhibit ice growth (20-24). Hydrogen bonding and other roles for the surrounding residues have also been considered (24-29). However, a model that explains the selective interaction of HPLC6 with the [2 0 <A><AC>2</AC><AC>&cjs1171;</AC></A> 1] interface has not emerged (for a full description of the different ice interfaces see the previous review (12)). Recent computational studies on the nature of the ice/water interface have allowed the first real simulations of the interaction of HPLC6 with the fluid interface to be carried out (30). These studies support experimental data on mutants (20-24) that have shown that hydrogen bonding involving the hydroxyl groups of the four Thr residues is not the primary reason for the interaction of HPLC with the ice/water interfacial region.

In contrast to HPLC6, type I AFPs from the grubby sculpin (Myoxocephalus aenaeus) (31), the shorthorn sculpin (Myoxocephalus scorpius) (3, 32), and the Arctic sculpin (Myoxocephalus scorpioides) (33) have been much less studied. These proteins differ from both HPLC6 and sequences from the right-eye flounders in the N-terminal region of the sequence. The N-terminal residues of the sculpin proteins (e.g. SS3, SS8 in Table I) include established helix-breaking residues followed by an 11-residue repeat unit that is similar to the Thr-X2-Asx-X7 repeat present in the other type I proteins (12).

Two proteins, XSS3 and XSS8 (Table I), have been isolated from the blood serum of the shorthorn sculpin (3). It has been estimated using CD spectroscopy that XSS8, the major component, is more helical than XSS3, and it has been proposed that there are two different structural and possibly functional domains, the nine-residue N terminus and the alanine-rich helical region between residues 8 and 42 (3). Vacuum phase molecular dynamics studies on SS8, a closely related sequence to XSS8, concluded that the polypeptide conformation resembles an idealized alpha -helix, except for a short section of the N-terminal region (34). This study also proposed that SS8 acts via insertion of the side chains of the Arg and Lys residues into the ice lattice. However, no experimental or condensed-phase computational evidence exists to support these conclusions. Of particular significance is the fact that the sculpin proteins accumulate specifically at a different ice plane than the winter flounder protein HPLC6 (15). The origin of this difference in specificity between the flounder and sculpin proteins is not understood and must eventually be explained by any proposed model(s) of ice growth inhibition by the type I AFPs. Recent structure-activity studies on SS8 (that was independently isolated and resequenced) propose a mechanism that involves appreciable hydrophobic interactions, with the lysine residues enhancing solubility (35).

The lack of understanding of the one or more mechanisms through which the type I AFPs inhibit ice growth has also hampered the realization of industrial and biotechnological applications (6, 7). Furthermore, the production of these proteins using solid-phase synthesis (which has been used to produce almost all the analogues of HPLC6 reported to date) is unsuitable for the large scale production of structural variants of the wild-type proteins. In this paper, we address both these issues by producing a type I polypeptide from the shorthorn sculpin (rSS3) using recombinant methods.2 This has allowed complete 1H and 15N resonance assignments and characterization of the solution conformation of rSS3 using heteronuclear NMR experiments. Ice growth inhibition studies on rSS3 and an acetylated derivative have provided important new clues regarding the mechanism of action of these proteins and have allowed a new contribution to the mechanism to be proposed to explain the unique interaction of the sculpin AFPs with ice.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials-- SS3 prepared by solid-phase peptide synthesis (sSS3) was supplied by Auspep Pty. Ltd. (Melbourne) at >90% purity.

Cloning and Overexpression of rSS3-- A synthetic gene encoding SS3 was constructed from the following three overlapping primers: 1) AFP1 (GG GGA TCC ATG AAC GCT CCG GCA CGT GCA GCT GCG AAA ACT GCA GCT GAC GCA CTG GCT G), AFP2 (GCA GCA GCC GCA GCG TCT GCC GCG GTT TTT TTT GCT GCA GCC AGT GCG TCA GCT GCA GTT), and AFP3 (CGG CAG ACG CTG CGG CTG CGG CTG CTG CGG CAG CTG CTT AAT AGT GAG AAT TCG G) using overlap extension (36). The three primers were annealed, and PCR was used to fill the gaps. Two end primers, AFPPRIM1 (GG GGA TCC ATG AAC GCT C) and AFPPRIM2 (CCG AAT TCT CAC TAT TAA GC), were then used to amplify the gene by PCR. The amplified product was inserted into pGEX-2T using the BamHI and EcoRI restriction sites and used to transform Escheichia coli (DH5alpha ). Transformant colonies selected for growth on ampicillin were screened for the insert DNA by PCR. Plasmid DNA was purified from positive clones and sequenced. Plasmid DNA from a single clone identified as containing the rSS3 gene was used to transform E. coli (BL21(DE3)) for protein production.

Overnight cultures from freshly transformed E. coli BL21(DE3) cells were used to inoculate Luria broth containing 150 µg ml-1 ampicillin. The cells were grown at 37 °C with shaking (200 rpm), and expression was induced using isopropyl-1-thio-beta -D-galactopyranoside (0.4 mM) when the absorbance at 600 nm (A600) was ~0.6. The cells were allowed to grow for a further 4-6 h at 25 °C and were then harvested by centrifugation (15 min, 5000 × g, 4 °C). The cell pellets were resuspended in lysis buffer (20 mM Tris, pH 8.0; 150 mM NaCl; 0.5 mM phenylmethylsulfonyl fluoride; 0.1% (v/v) beta -mercaptoethanol) and lysed by either sonication or five passages through a Rannie Mini-lab 8.30H homogenizer at 500 kPa.

The lysate was centrifuged (20 min, 15,000 × g, 4 °C), the insoluble fraction was discarded, and the soluble fraction was passed through a column containing 15 ml of glutathione-Sepharose 4B (Amersham Biosciences, Inc.) equilibrated with lysis buffer. The column was washed with 100 ml of wash buffer (50 mM Tris, pH 8.0; 100 mM NaCl; 10% glycerol; 1.4 mM phenylmethylsulfonyl fluoride; 1.4 mM beta -mercaptoethanol) and re-equilibrated with 120 ml of thrombin buffer (50 mM Tris, pH 8.0; 150 mM NaCl; 2.5 mM CaCl2). After incubation with thrombin (100 units) for 1 h at 37 °C, the cleaved rSS3 was eluted with thrombin buffer in four 25-ml fractions, snap frozen, and stored at -20 °C.

Large scale overexpression was carried out in a New Brunswick Scientific Bioflow III Fermentor using the protocol of Cai et al. (37). Three-liter cultures were grown on a minimal medium, in which the only source of nitrogen was ammonium chloride. For the production of 15N-labeled SS3, 15NH4Cl (0.75 g) was added to the medium when the dissolved oxygen content of the medium increased sharply (indicating exhaustion of the ammonium chloride). Following a second increase in dissolved oxygen content, 3.75 g of 15NH4Cl was added, overexpression was induced, and the culture was allowed to grow for a further 5 h before harvesting as described above.

HPLC Purification-- All recombinant samples were purified by reverse-phase HPLC using an Alltech Altima 5-µm C18 column. A linear AB gradient was used (30-45% buffer B over 15 min for rSS3 and 15N-rSS3; 20-60% buffer B over 30 min for 4Ac-rSS3). In each case a flow rate of 1 ml/min was used, and the eluate was monitored at 215 and 280 nm. The major peaks were collected, lyophilized, and stored at -20 °C. The identity of rSS3 and 15N-rSS3 was confirmed by electrospray mass spectrometry (rSS3: Mr,calc = 3084 Da; Mr,expt = 3083 ± 1 Da; 15N-rSS3: Mr,calc = 3125 Da; Mr,expt = 3124 ± 2 Da).

Acetylation of r-SS3-- rSS3 (4.0 mg) was dissolved in water (50 µl) and sodium acetate solution (saturated, 50 µl) added. The mixture was stirred at 0 °C, and acetic anhydride (10 µl, 9.4 µmol) was added in five equal amounts over 2 h. The mixture was allowed to react for a further 2 h at 0 °C, and then subjected to reverse phase HPLC; products were identified by electrospray mass spectrometry. Products with three or fewer acetyl groups were resubjected to the reaction conditions. Fractions containing 4Ac-rSS3 were combined (Mr,calc = 3152 Da, Mr,expt = 3150 ± 5 Da).

Circular Dichroism Studies-- CD measurements were made using a Jasco J-710 spectropolarimeter equipped with a 0.1-cm water-jacketed cell connected to a NESLAB RTE-111 water bath. Peptide samples were between 0.1 and 0.5 mg ml-1 in water or 100 mM NH4HCO3 buffered solutions, at pH 8.5. The sample pH was adjusted using 0.1 M NaOH and HCl solutions as required. Variable temperature measurements were made at regular intervals between 2 °C and 50 °C. Sample concentrations for CD and thermal hysteresis measurements were determined by amino acid analysis, which was carried out by Baylor College of Medicine, Houston, TX. Helicity values were calculated by the method of Greenfield and Fasman (38).

Thermal Hysteresis-- Ice crystals in a Clifton nanoliter osmometer were observed through a microscope and photographed with a digital camera, and time evolution was recorded by a video camera linked to a video recorder (see Ref. 21). Still images were also obtained from the videotape record at regular intervals over a period of ~1 min. The absolute length scale in the video images was determined from previous measurements of the absolute diameter of the holes in the (unchanged) aluminum sample holder (21).

NMR Spectroscopy-- NMR samples of rSS3, 15N-rSS3, and 4Ac-rSS3 were prepared by dissolving lyophilized peptide in 550 µl of 90% H2O/10% D2O to final concentrations of 1 mM. The pH was adjusted to 5.0 using NaOH. The following homonuclear two-dimensional experiments were recorded: TOCSY (tau m = 35, 70 ms; (39)), DQF-COSY (40), and NOESY (tau m = 70, 100, and 250 ms (41)). Three-dimensional HNHA (42) and NOESY-HSQC (43) experiments were used to assign the [15N,1H]HSQC spectrum of rSS3, and the HNHA was used to derive 3JHNa coupling constants. Spectral widths were typically 12 ppm for 1H and 30 ppm for 15N. 2,2-Dimethylsilapentane-5-sulfonic acid (20 µM) was added as an internal reference. Spectra were recorded on Bruker DRX600 spectrometers equipped with an HCN triple-resonance probe head. Water suppression was achieved by the use of pulsed-field gradients, and quadrature detection in the indirect dimensions was accomplished using the States-time proportional phase incrementation method (43). Spectra were processed as described previously (44) and were analyzed using the program XEASY (45).

Samples in aligned media for the measurement of residual dipolar couplings were prepared using the method of Ruckert and Otting (46). Briefly, polyoxyethylene 5-octyl ether was dissolved in 90% H2O/10% D2O to a final concentration of 5% (w/w), the pH was adjusted to 5.0, and 1-octanol was added in microliter steps, with vigorous shaking, to a final molar ratio of 0.87 (polyoxyethylene 5-octyl ether:1-octanol). Formation of the La phase was detected by the solution becoming instantaneously transparent and opalescent. 15N-Labeled rSS3 was added from a stock solution (1.2 mM, pH 5.0) to a final concentration of 200 µM. All spectra were recorded at 278 K. Measurements of 1DHNN were made by comparing 15N-HSQC spectra, recorded without 15N-decoupling in F2, in aligned and unaligned media.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Overexpression and Purification-- Because type I AFPs are relatively small proteins (3000-5000 Da) that lack a globular shape, they are potentially susceptible to degradation when expressed in heterologous systems such as bacteria. For this reason rSS3 was expressed as a fusion with the 26-kDa C-terminal domain of GST from Schistosoma japonicum. This fusion protein was expected to show greater stability in bacteria than rSS3 on its own, and indeed no degradation was observed when expressed in E. coli. The fusion protein was present in approximately equal amounts in the insoluble and soluble components at 37 °C, and reduction of the temperature at which the bacterial cells were induced from 37 °C to 25 °C resulted in ~80% soluble fusion protein (data not shown). Cleavage of the bound protein between the GST and SS3 domains using the site-specific protease thrombin resulted in the production of the sculpin sequence with two additional residues (Gly-Ser) appended to the N terminus (rSS3). Fig. 1 shows the affinity purification of rSS3; the presence of a single band in lane 4 indicates that no appreciable breakdown of the SS3 portion of the fusion protein was observed. The yield from 4 liters of bacterial culture was 7.5 mg of rSS3, at >90% purity.


View larger version (78K):
[in this window]
[in a new window]
 
Fig. 1.   Tricine SDS-PAGE gel of purification of rSS3. Lane 1, molecular weight markers (Invitrogen); lane 2, total soluble protein; lane 3, flow-through; lane 4, GST-rSS3 fusion protein bound to reduced glutathione-Sepharose; lane 5, bound GST following thrombin cleavage; lane 6, purified rSS3.

The Solution Conformation of SS3-- To characterize the solution conformation of SS3 and to ascertain whether the addition of two non-native residues onto the N terminus had a significant effect on the solution properties of the protein, we used a combination of circular dichroism and NMR methods. CD spectra of sSS3 and rSS3 recorded over a range of temperatures (Fig. 2) indicated that both the synthetic and recombinant versions of SS3 are alpha -helical and that the helicity increased substantially as the temperature was lowered. At 2 °C, rSS3 was estimated to be 40% alpha -helical. This value is comparable to the previously reported literature estimate of 45% for XSS3 (3).


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 2.   CD spectra of rSS3. Spectra were recorded on 30 µM sample at pH 5.0 between 2 and 40 °C. Calculated helicity at 2 °C is 42%.

The 600-MHz 1H NMR spectrum of rSS3 was assigned using a combination of three-dimensional HNHA and NOESY-HSQC experiments, together with DQF-COSY, TOCSY, and NOESY spectra, all recorded at 5 °C. Despite the high degree of signal overlap resulting from a combination of the 25 alanine residues and the helical conformation, assignments were made for every resonance in the spectrum (Fig. 3). This result contrasts with the difficulties experienced in previous NMR studies of the naturally occurring type I AFP, HPLC6 (47, 48). In the current study, the assignment process was assisted by the availability of uniformly 15N-labeled polypeptide 15N-rSS3, emphasizing the utility of protein production in a recombinant system.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 3.   600-MHz NMR spectra of rSS3 showing spin system assignments. Spectra were recorded on a 1 mM sample in 90% H2O at pH 5.0. a, TOCSY experiment (mixing time 70 ms); b, 15N HSQC spectrum. Side-chain protons are denoted SC.

Analysis of the NOESY spectra, in particular the amide-amide region (Fig. 4), revealed many of the characteristic connectivities expected for an alpha -helix. A summary of medium range NOEs, Halpha chemical shift data, and 3JHNalpha scalar coupling values is presented in Fig. 5. For Halpha chemical shifts, a series of negative values for delta (Halpha )rSS3 - delta (Halpha )coil are indicative of helical structure. The values were negative for all residues apart from Gly-(-1)-Met-1, Ala-3, and Leu-15, consistent with most of the polypeptide adopting an alpha -helical conformation. Similarly, values of 3JHNalpha , which are typically <~6 Hz for alpha -helices (49), and NOE patterns support a predominantly alpha -helical conformation, although a number of the expected medium range NOEs could not be unambiguously identified because of resonance overlap.


View larger version (55K):
[in this window]
[in a new window]
 
Fig. 4.   Amide region of a 600-MHz NOESY spectrum of rSS3. Spectra were recorded on a 1 mM sample in 90% H2O at pH 5.0 with a mixing time of 250 ms. Sequential dNN(i,i+1) connectivities typical of an alpha -helix are highlighted for residues 15-35.


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 5.   Summary of NMR parameters measured for rSS3. Below the amino acid sequence, filled circles identify residues with 3JHNHalpha  < 6.0 Hz, indicative of local alpha -type conformation; crosses identify residues with 3JHNHalpha values of 6.0-8.0 Hz. For the sequential NOE connectivities (dalpha N, dNN, and dbeta N) thin and thick bars indicate strong and weak NOE intensity, respectively; bracketed values are for X-Pro and Pro-X. Clearly identified medium range NOEs are indicated by a black line connecting the two residues, whereas overlapped NOEs are identified by a light gray line. 1Halpha chemical shift changes relative to random coil values, Delta delta (1Halpha ), are plotted and ranged from -0.29 to 0.16 ppm; negative values are indicative of an alpha -helical conformation. Residual dipolar couplings, 1DHNN, are plotted at the bottom. Values were measured for all protons directly attached to nitrogen and covered the range -11.4 to 3.1 Hz. The location of the identified alpha -helix is shown at the bottom.

An issue that often arises when using NMR methods to characterize the solution conformation of rod-shaped proteins is that of whether the overall shape is straight or bent. Most NMR-derived structural constraints are short-range in nature (e.g. NOEs scalar coupling constants), and are therefore poorly suited to defining the relative conformations of the two ends of a rod. However, residual dipolar couplings, measured in weakly aligning media such as dilute solutions of liquid crystals, have recently been shown to be well suited to this task (50-52), and the availability of a recombinant form of SS3 allows these parameters to be measured. We measured residual 1H-15N dipolar couplings (1DHN) for the backbone amide protons of 15N-rSS3, and the results are shown at the bottom of Fig. 5. The magnitude of these couplings is an indication of the angle formed between the N-H bond vector and the bulk magnetic field and can, therefore, be used to infer the angular relationship between two N-H bond vectors within a single molecule. The observation that the values of 1DHN are rather uniform across most of the polypeptide is consistent with a conformation in which all N-H bond vectors are oriented in approximately the same direction, as would be expected for an alpha -helix with no significant kink. Notably, the values of 1DHN tail off toward zero toward the N terminus, consistent with the helical structure in this region being more flexible than the rest of the polypeptide. Further refinement of this data to obtain a full structure would require additional constraints from measurements on doubly labeled (13C,15N) polypeptide.

Thermal Hysteresis of sSS3 and rSS3-- The thermal hysteresis values for sSS3 and rSS3 were measured by nanoliter osmometry in unbuffered aqueous solutions on 4 mM, 2 mM, and 1 mM polypeptide samples at pH 5; concentrations of each stock solution were determined by amino acid analysis. Fig. 6a shows a single crystal of ice grown from a solution of purified rSS3 at 16 mg/ml. The hexagon bipyramidal crystals are characteristic of kinetic ice growth inhibitors of this type. The behavior of sSS3 (>90% pure) was similar but yielded truncated bipyramidal crystals or "barrels," again a signature of ice modification. Similar barrels were obtained with an independent sample of rSS3 of lower purity than the sample used to obtain the crystals shown in Fig. 6a. Both sSS3 and rSS3 exhibited negligible hysteresis values of between zero and 0.02 °C at concentrations up to 18 mg/ml (data not shown). The ability to facet growing ice crystals, but not inhibit their growth at all, as shown by both sSS3 and rSS3, is typical of polypeptides that interact weakly with the broad ice/water interfacial region.


View larger version (83K):
[in this window]
[in a new window]
 
Fig. 6.   Ice crystal morphology. Single ice crystals grown in the presence of solutions of (a) rSS3 (18 mg ml-1) and (b) 4Ac-rSS3 (16 mg ml-1). The long axis of each crystal is ~50 µm.

The wild-type protein isolated from blood serum (XSS3) has been reported to exhibit measurable thermal hysteresis (3). Although no raw data were presented, XSS3 was reported to give 0.39 degrees hysteresis (~10 mg/ml, 0.02 M NH4HCO3), whereas the second major protein isolated from the fish, XSS8, gave a higher hysteresis value of 0.67 °C. Both proteins contained an unknown blocking group at the N terminus (designated by X in these sequences in Table I), and removal of this group from XSS8 to give NH2SS8, decreased the hysteresis by 0.41 degrees. Although the effect of the removal of the blocking group from XSS3 was not reported, a similar reduction in thermal hysteresis to that observed with XSS8 would result in negligible thermal hysteresis, consistent with the results obtained with rSS3 and sSS3.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Polypeptide sequences

Acetylation of rSS3-- To determine whether a post-translational modification of SS3 may affect its ability to act as an AFP and to test the hypothesis that the Lys/Arg residues are required for activity (34), we chose to acetylate the free amino groups on the polypeptide. Reaction of rSS3 with acetic anhydride under standard conditions, followed by reverse-phase HPLC, yielded 4Ac-rSS3 in which all three lysine residues and the N terminus were derivatized with acetyl groups. The identity of this polypeptide was confirmed by mass spectrometry and NMR spectroscopy. Complete assignments of the 1H resonances using two-dimensional NMR methods revealed that there were no significant conformational changes in 4Ac-rSS3; all Halpha resonances were located less than 0.05 ppm from their position in the unacetylated peptide.

Remarkably, 4Ac-rSS3 exhibits not only faceting of growing ice crystals (Figs. 6b and 7) but also substantial thermal hysteresis (Fig. 8), suggesting that either blockage of the N terminus and/or acetylation of the three lysine residues (Lys-10, Lys-20, Lys-21) is important for activity. The time evolution of an ice crystal is shown for the highest concentration studied in Fig. 7.


View larger version (56K):
[in this window]
[in a new window]
 
Fig. 7.   Video microscopy. Ice crystal growth in the presence of 4Ac-rSS3 (16 mg ml-1); still images are taken at regular intervals over a period of 1 min. The long axis of the largest crystal is ~50 µm. After the last image, further lowering of the temperature by ~0.45 °C produced no further ice growth, yielding the thermal hysteresis reported in Fig. 8.


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 8.   Thermal hysteresis. Measurements were carried out in triplicate with 4Ac-rSS3 (pH 5) as a function of concentration. Solid line is an approximate fit to guide the eye based on the functional form of the Langmuir adsorption isotherm.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Compared with the type I winter flounder proteins (in particular HPLC6), much less is known about the type I sculpin proteins. There are no x-ray or NMR structures of AFPs from any of the sculpin proteins, and, with the exception of a very recent report on SS8 (35), systematic structure-activity studies to determine the residues that are crucial for activity have not been reported. The sculpin proteins are important, given that SS8 was proposed to interact with the ice surface based on the spacing of Lys-9, Lys-23, Lys-31, and Arg-12 (34); i.e. a completely different mechanism to that proposed for HPLC6 and other synthetic flounder AFPs, including VVVV2KE, in which hydrophobic interactions play a dominant role in the mechanism (21, 23, 24, 29, 30). We have previously noted that a common hydrophobic face is present in all type I proteins, including the sculpins (12), and hence proposed that the type I AFPs act via a common mechanism. Very recently this hypothesis has been confirmed by point mutations made on SS8, which have identified the alanine-rich surface as oriented toward ice, and the charged residues oriented toward liquid water (35).

Despite the presence of a common hydrophobic face in all type I AFPs (12), the sculpins accumulate at a different ice plane than the flounder proteins; the winter flounder sequence HPLC6 (and the synthetic mutant VVVV2KE) accumulates on the 12 equivalent {2 0 <A><AC>2</AC><AC>&cjs1171;</AC></A> 1} bipyramidal planes of the ice 1h crystal (15) whereas the shorthorn sculpin (and the synthetic mutant AAAA2KE) accumulates on the six equivalent {2 <A><AC>1</AC><AC>&cjs1171;</AC></A> <A><AC>1</AC><AC>&cjs1171;</AC></A> 0} planes (34) (for a detailed description of the origin and naming of the different ice planes see for example Ref. 12). The origin of this difference is not understood, but an obvious structural difference between the natural flounder and sculpin sequences is the N-terminal region of the polypeptides (Table I).

We chose SS3, as one of the simplest sculpin proteins, to prepare and investigate the solution conformation, particularly of the N-terminal region, and to allow preparation of a simple acetylated derivative that would establish the residues that are required for antifreeze activity. A highly effective expression system for production of the protein as a GST fusion was developed, which yielded milligram quantities of purified rSS3 from a few liters of bacterial culture. After affinity chromatography and reverse-phase HPLC, rSS3 was >99% pure, a level of purity much greater than sSS3, or other related proteins that our laboratory has produced using solid-phase peptide synthesis (21, 23, 53). Thus, in our hands, the expression of rSS3 is superior to solid-phase production of sSS3 in terms of the time required for the synthesis, overall cost, and the purity of the isolated protein. The recombinant system also offers the additional advantages of simple and inexpensive production of mutants (which may be used for mechanistic or biotechnological studies) and the ability to produce isotopically labeled forms of the protein (e.g. 15N-rSS3 or 15N,13C-rSS3) for detailed structural analysis using NMR spectroscopy.

Although CD measurements are consistent with ~42% helicity at 2 °C, NMR studies (Figs. 3 and 4) provide clear evidence that rSS3 is highly structured and predominantly alpha -helical in conformation at low temperature. Examination of the NMR parameters presented in Fig. 5 suggests that residues 5-33 of rSS3 adopt a stable alpha -helical conformation, whereas residues 1-4 are partially helical. This corresponds to an overall helicity of ~80-90% (taking into account the non-native residues -2 and -1 that were introduced by the cloning procedure). It is interesting that there is such a large apparent difference between the estimates of helicity based on CD and NMR data. This is most likely related to the method used to estimate helicity from CD data (38), which is not well suited to proteins containing non-helical secondary structure. Alternatively, there may be some flexibility in the helix (especially near the termini) that reduces the CD value and is not accurately reflected in the NMR parameters we have measured. This issue will be resolved when a full structure determination is carried out using more NMR data.

For comparison, vacuum modeling has predicted that SS8 adopts a fully alpha -helical conformation (34), whereas more recent molecular dynamics calculations on SS8 have predicted that the N-terminal cap structure folds the N terminus up and away from the Ala-rich surface of the protein (35). Although direct comparisons between the conformation of residues 1-10 of SS3 and SS8 cannot be made, our results suggest that the first 10 residues of SS3 are aligned approximately parallel to the alpha -helix formed by residues 11-33, with no significant deviation similar to that predicted for SS8 (35). Further structural constraints derived from 15N,13C-labeled protein (including 13C-X residual dipolar couplings) are required to fully refine the structure.

Although both sSS3 and rSS3 cause faceting of the ice crystals to occur, zero or very low thermal hysteresis values were measured. Thus, both polypeptides behave as ice growth modifiers (12) rather than as true kinetic ice growth inhibitors or AFPs. The measured hysteresis value is significantly lower than that reported from SS3 isolated from sculpin blood serum (3). However, both of the naturally occurring sculpin proteins XSS3 and XSS8 isolated and characterized by Hew et al. (3) contained an uncharacterized blocked N terminus. In the case of SS8, cleavage of this blocking group reduced the thermal hysteresis (Table I). Thus, the difference between the measured hysteresis values for sculpin XSS3 (0.37 °C) and the synthetic sSS3/rSS3 polypeptides (0.0 °C) is consistent with the requirement of an N-terminal blocking group for activity.

The thermal hysteresis and characteristic ice faceting of 4Ac-rSS3 (Figs. 6-8) show that not only is this derivative a true kinetic ice growth inhibitor, but also that this derivative is more active than rSS3, which exhibited negligible hysteresis. These results conclusively rule out an inserted charge mechanism, similar to that proposed for SS8 involving the protonated lysine amino groups and the arginine side chain (34) and support our earlier hypothesis that the hydrophobic face is important in the mechanism of ice growth in both the winter flounder and sculpin proteins (12). Our hypothesis is also supported by the very recent work by Baardnes et al. (35) on SS8 in which point mutations of the hydrophobic face were seen to switch off antifreeze activity. This study also identified the blocking group as an acetyl group and, although SS3 was not studied, it seems plausible that the blocking group X is the same in both SS3 and SS8.

Fig. 9 shows a helical wheel representation of SS3 with the hydrophilic face containing the highlighted lysine residues proposed to be oriented toward liquid water. The increase in hysteresis that occurred following acetylation of rSS3 is consistent with two current hypotheses. First, it supports a role for the N-terminal group in activity, originally proposed by Hew et al. (3). The N-terminal blocking group may affect several properties of the polypeptide, including overall charge, dipole moment, N-terminal capping network, and solution conformation, all of which need to be considered in further refinement of the mechanism for ice growth inhibition.


View larger version (42K):
[in this window]
[in a new window]
 
Fig. 9.   Helical wheel representation of SS3. Lysine residues that are acetylated in 4Ac-rSS3 are shown in bold on the hydrophilic face which is opposite the hydrophobic face. Similar hydrophobic faces in type I AFPs have previously been noted in reference (12).

In addition, our recent studies have shown that there is significant charge inhomogeneity at the ice/water interface (54, 55). The full charge distribution of SS3, or any polypeptide, interacts with the charge inhomogeneity that occurs naturally at any broad interface such as the ice/water interface. This full charge distribution may be summarized crudely by the dipole moment of the polypeptide. Thus we have proposed that, next in importance to hydrophobicity, the overall charge distribution of the polypeptide is a crucial factor that influences the exact interface at which the polypeptide accumulates (55). A consequence of this hypothesis is that enhancing the charge distribution in the polypeptide will increase the strength of the interaction with the ice/water interface (55) and lead to greater thermal hysteresis. Hence, the observed increased thermal hysteresis of the acetylated derivative 4Ac-rSS3 compared with rSS3, which enhances the molecular charge distribution, is consistent with this hypothesis. However, slightly different conformations of the native protein from the fish, rSS3, and 4Ac-rSS3 cannot be ruled out as contributor to the different thermal hysteresis values. Further NMR studies to determine full structures of these AFPs would be informative in this regard.

In summary, this study reports the first recombinant production, solution conformation, and preparation and ice growth inhibition properties of an acetylated derivative of the 33-residue AFP from the shorthorn sculpin. Together with recent independent studies on the 42-residue shorthorn sculpin AFP, SS8 (35), these data confirm our hypothesis (12) that all type I AFPs contain a common hydrophobic face that is required for antifreeze activity. Beyond supporting the hydrophobicity mechanism, the data are consistent both with a proposed role for the N-terminal blocking group (3) and with the proposed role of the interaction of the overall charge distribution of the peptide with the ice/water interface (55). The complete details of the accumulation of SS3 at the specific {2 <A><AC>1</AC><AC>&cjs1171;</AC></A> <A><AC>1</AC><AC>&cjs1171;</AC></A> 0} ice plane require further detailed molecular simulations and experimental studies.

    FOOTNOTES

* This research was supported in part by a University of Sydney Sesquicentennial Research and Development Grant (to M. M. H.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

** Supported by the Welch Foundation and Grant ARP 003652- 0303-1999.

Supported by an Australian Postgraduate Award.

Dagger Dagger To whom correspondence may be addressed: The School of Chemistry, University of Sydney, New South Wales 2006, Australia. Tel.: 61-2-9351-2745; Fax: 61-2-9351-6650; E-mail: harding@chem.usyd.edu.au.

§§ An ARC Research Fellow. To whom correspondence may be addressed: The Department of Biochemistry, University of Sydney, New South Wales 2006, Australia. Tel.: 61-2-9351-3906; Fax: 61-2-9351-4726; E-mail: j.mackay@biochem.usyd.edu.au.

Published, JBC Papers in Press, April 8, 2002, DOI 10.1074/jbc.M200307200

2 Presented in part at the IUPAC World Chemistry Congress, Brisbane, Australia, July 2001 and the Novartis Foundation/Royal Society Discussion Meeting, London, UK, September 28, 2001.

    ABBREVIATIONS

The abbreviations used are: AFP, antifreeze polypeptide; SS, shorthorn sculpin; HPLC, high performance liquid chromatography; CD, circular dichroism; GSH, glutathione; GST, glutathione S-transferase; TFA, trifluoroacetic acid; TOCSY, total correlation spectroscopy; NOESY, nuclear Overhauser effect spectroscopy; DQF-COSY, double-quantum filtered correlation spectroscopy; HSQC, homonuclear single quantum coherence.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Duman, J. G., and DeVries, A. L. (1974) Nature 247, 237-238[CrossRef]
2. Duman, J. G., and DeVries, A. L. (1976) Comp. Biochem. Physiol. B 54, 375-380[CrossRef][Medline] [Order article via Infotrieve]
3. Hew, C. L., Joshi, S., Wang, N.-C., Kao, M.-H., and Ananthanarayanan, V. S. (1985) Eur. J. Biochem. 151, 167-172[Medline] [Order article via Infotrieve]
4. Chao, H., Davies, P. L., and Carpenter, J. F. (1996) J. Exp. Biol. 199, 2071-2076[Abstract]
5. Brown, C. J. (1997) Can. Med. Assoc. J. 156, 629
6. Fletcher, G. L., Goddard, S. V., and Wu, Y. L. (1999) Chemtech 29, 17-28
7. Feeney, R. E., and Yeh, Y. (1998) Trends Food Sci. Technol. 9, 102-106
8. Rubinksy, B. (2000) Ann. Rev. Biomed. Eng. 2, 157-187[CrossRef][Medline] [Order article via Infotrieve]
9. Wang, J.-H. (2000) Cryobiology 41, 1-9[CrossRef][Medline] [Order article via Infotrieve]
10. Yeh, Y., and Feeney, R. E. (1996) Chem. Rev. 96, 601-617[CrossRef][Medline] [Order article via Infotrieve]
11. Davies, P. L., and Sykes, B. D. (1997) Curr. Opin. Struct. Biol. 7, 828-834[CrossRef][Medline] [Order article via Infotrieve]
12. Harding, M. M., Ward, L. G., and Haymet, A. D. J. (1999) Eur. J. Biochem. 264, 653-665[Medline] [Order article via Infotrieve]
13. Ewart, K. V., Lin, Q., and Hew, C. L. (1999) Cell. Mol. Life Sci. 55, 271-283[CrossRef][Medline] [Order article via Infotrieve]
14. Fourney, R. M., Joshi, S. B., Kao, M. H., and Hew, C. L. (1984) Can. J. Zool. 62, 28-33
15. Knight, C. A., Cheng, C.-H. C., and DeVries, A. L. (1991) Biophys. J. 59, 409-418[Medline] [Order article via Infotrieve]
16. Chou, K. C. (1992) J. Mol. Biol. 223, 509-517[CrossRef][Medline] [Order article via Infotrieve]
17. Wen, D., and Laursen, R. A. (1992) Biophys. J. 63, 1659-1662[Medline] [Order article via Infotrieve]
18. Jorgensen, H., Mori, M., Matdui, H., Kanaoka, M., Yanagi, H., Yabusaki, Y., and Kikuzono, Y. (1993) Protein Eng. 6, 19-27[Abstract/Free Full Text]
19. Lal, M., Clark, A. H., Lips, A., Ruddock, J. N., and White, D. N. J. (1993) Faraday Discuss. Chem. Soc. 95, 299-306[CrossRef]
20. Chao, H., Houston, M. E., Hodges, R. S., Kay, C. M., Sykes, B. D., Loewen, M. C., Davies, P. L., and Sönnichsen, F. D. (1997) Biochemistry 36, 14652-14660[CrossRef][Medline] [Order article via Infotrieve]
21. Haymet, A. D. J., Ward, L. G., Harding, M. M., and Knight, C. A. (1998) FEBS Lett. 430, 301-306[CrossRef][Medline] [Order article via Infotrieve]
22. Zhang, W., and Laursen, R. A. (1998) J. Biol. Chem. 273, 34806-34812[Abstract/Free Full Text]
23. Haymet, A. D. J., Ward, L. G., and Harding, M. M. (1999) J. Am. Chem. Soc. 121, 941-948[CrossRef]
24. Baardsnes, J., Kondejewski, L. H., Hodges, R. S., Chao, H., Kay, C., and Davies, P. L. (1999) FEBS Lett. 463, 87-91[CrossRef][Medline] [Order article via Infotrieve]
25. Sicheri, F., and Yang, D. S. C. (1995) Nature 375, 427-431[CrossRef][Medline] [Order article via Infotrieve]
26. Wen, D., and Laursen, R. A. (1993) FEBS Lett. 317, 31-34[CrossRef][Medline] [Order article via Infotrieve]
27. Cheng, A. L., and Merz, K. M. (1997) Biophys. J. 73, 2851-2873[Medline] [Order article via Infotrieve]
28. McDonald, S. M., White, A., Clancy, P., and Brady, J. W. (1995) AIChE J. 41, 959-973[CrossRef]
29. Loewen, M. C., Chao, H. M., Houston, M. E., Baardsnes, J., Hodges, R. S., Kay, C. M., Sykes, B. D., Sönnichsen, F. D., and Davies, P. L. (1999) Biochemistry 38, 4743-4749[CrossRef][Medline] [Order article via Infotrieve]
30. Dalal, P., Knickelbein, J., Haymet, A. D. J., Sönnichsen, F. D., and Madura, J. D. (2001) Phys. Chem. Commun. 7, 1-5
31. Chakrabartty, A., Hew, C. L., Shears, M., and Fletcher, G. (1988) Can. J. Zool. 66, 403-408
32. Fletcher, G. L., Addison, R. F., Slaughter, D., and Hew, C. L. (1982) Arctic 35, 302-306
33. Yang, D. S. C., Sax, M., Chakrabartty, A., and Hew, C. L. (1988) Nature 333, 232-237[CrossRef][Medline] [Order article via Infotrieve]
34. Wierzbicki, A., Taylor, M. S., Knight, C. A., Madura, J. D., Harrington, J. P., and Sikes, C. S. (1996) Biophys. J. 71, 8-18[Medline] [Order article via Infotrieve]
35. Baardnes, J., Jelokhani-Niaraki, M., Kondejewski, L. H., Kuiper, M. J., Kay, C. M., Hodges, R. S., and Davies, P. L. (2001) Protein Sci. 10, 2566-2576[CrossRef][Medline] [Order article via Infotrieve]
36. Higuchi, R., Krummel, B., and Saiki, R. K. (1988) Nucleic Acids Res. 16, 7351-7367[Abstract/Free Full Text]
37. Cai, M., Huang, Y., Sakaguchi, K., Clore, G. M., Gronenborn, A. M., and Craigie, R. (1998) J. Biomol. NMR 11, 97-102[CrossRef][Medline] [Order article via Infotrieve]
38. Greenfield, N., and Fasman, G. D. (1969) Biochemistry 8, 4108-4116[CrossRef][Medline] [Order article via Infotrieve]
39. Bax, A., and Davis, D. G. (1985) J. Magn. Reson. 65, 355-360
40. Rance, M., Sorensen, O., Bodenhausen, G., Wagner, G., Ernst, R., and Wuthrich, K. (1983) Biochem. Biophys. Res. Commun. 117, 479-485[CrossRef][Medline] [Order article via Infotrieve]
41. Kumar, A., Ernst, R. R., and Wüthrich, K. (1980) Biochem. Biophys. Res. Commun. 95, 1-6[CrossRef][Medline] [Order article via Infotrieve]
42. Vuister, G. W., and Bax, A. (1993) J. Am. Chem. Soc. 115, 7772-7777[CrossRef]
43. Marion, D., Driscoll, P. C., Kay, L. E., Wingfield, P. T., Bax, A., Gronenborn, A. M., and Clore, G. M. (1989) Biochemistry 28, 6150-6156[CrossRef][Medline] [Order article via Infotrieve]
44. Kowalski, K., Czolij, R., King, G. F., Crossley, M., and Mackay, J. P. (1999) J. Biomol. NMR 13, 249-261[CrossRef][Medline] [Order article via Infotrieve]
45. Bartels, C., Xia, T. H., Billeter, P., Guntert, P., and Wüthrich, K. (1995) J. Biomol. NMR 6, 1-10
46. Ruckert, M., and Otting, G. (2000) J. Am. Chem. Soc. 122, 7793-7797[CrossRef]
47. Gronwald, W., Chao, H., Reddy, D. V., Davies, P. L., Sykes, B. D., and Sönnichsen, F. D. (1996) Biochemistry 35, 16698-16704[CrossRef][Medline] [Order article via Infotrieve]
48. Sönnichsen, F. D., Davies, P. L., and Sykes, B. D. (1998) Biochem. Cell Biol. 76, 284-293[CrossRef][Medline] [Order article via Infotrieve]
49. Bystrov, V. F. (1976) Prog. NMR. Spectrosc. 10, 41-81[CrossRef]
50. Tolman, J. R. (2001) Curr. Opin. Struct. Biol. 11, 532-539[CrossRef][Medline] [Order article via Infotrieve]
51. Prestegard, J. H., Al-, Hashimi, H. M., and Tolman, J. R. (2001) Q. Rev. Biophys. 33, 371-424
52. Bax, A., Kontaxis, G., and Tjandra, N. (2001) Methods Enzymol. 339, 127-174[Medline] [Order article via Infotrieve]
53. Haymet, A. D. J., Ward, L. G., and Harding, M. M. (2001) FEBS Lett. 491, 285-288[CrossRef][Medline] [Order article via Infotrieve]
54. Hayward, J. A., and Haymet, A. D. J. (2001) J. Chem. Phys. 114, 3713-3726[CrossRef]
55. Bryk, T., and Haymet, A. D. J. (2002) J. Chem. Phys., in press
56. Cheng, C. C., and DeVries, A. L. (1991) in Life under Extreme Conditions (DiPrisco, G., ed) , pp. 1-14, Springer-Verlag, Heidelberg, Germany


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/27/24073    most recent
M200307200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fairley, K.
Right arrow Articles by Mackay, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fairley, K.
Right arrow Articles by Mackay, J. P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement